LXRX - Latest News
Lexicon Pharmaceuticals, Inc. (LXRX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.04B. Beta to the broader market is 1.03.
The article list below shows the most recent LXRX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent LXRX Headlines
Lexicon Pharmaceuticals Q2 Earnings Call Highlights
marketbeat.com - Aug 6, 2026
Lexicon Pharmaceuticals NASDAQ: LXRX reported a wider second-quarter loss as revenue declined sharply from the prior-year period, while the company hi
Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2026 Earnings Call Transcript
seekingalpha.com - Aug 6, 2026
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals (LXRX) Reports Q2 Loss, Lags Revenue Estimates
zacks.com - Aug 6, 2026
Lexicon Pharmaceuticals (LXRX) came out with a quarterly loss of $0. 06 per share in line with the Zacks Consensus Estimate.
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
globenewswire.com - Aug 6, 2026
Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027 NDA resubmission activities for ZYNQUISTA ® in type 1 diabetes nearin
Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com - Jul 30, 2026
THE WOODLANDS, Texas, July 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its sec
How News Affects LXRX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track LXRX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked LXRX news questions
- What is the latest LXRX news headline?
- The most recent LXRX headline (Aug 6, 2026) is "Lexicon Pharmaceuticals Q2 Earnings Call Highlights". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the LXRX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What LXRX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual LXRX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.